Literature DB >> 2796254

[Liver function of patients with arterial hypoxemia in chronic obstructive respiratory tract disease and the effect of nasal oxygen insufflation].

G H Micklefield1, D Schött, H D Kuntz, B May, W T Ulmer.   

Abstract

Patients suffering from chronic obstructive airway disease often have arterial hypoxemia, which is more or less severe. If hypoxemia deteriorates the function of the liver is still unknown. The aim of this study was to determine, if a mostly oxygen dependent process of liver metabolism (galactose elimination capacity) is disturbed and if it can be increased by oxygen insufflation. Under the same conditions an oxygen independent process (indocyaninegreen clearance) should not be influenced. Our results show, that galactose elimination capacity under room air was pathologic and can be increased significantly by oxygen breathing. No change of indocyaninegreen clearance was seen under the same conditions. After termination of oxygen therapy the galactose elimination capacity was as bad as before oxygen breathing. Dysfunctions of the liver, which are caused by hypoxemia, can be positively influenced by oxygen, but only for the duration of oxygen insufflation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2796254     DOI: 10.1007/bf01725200

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  22 in total

1.  The handling of indocyanine green by the liver.

Authors:  G Paumgartner
Journal:  Schweiz Med Wochenschr       Date:  1975

2.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

3.  Studies of hepatic function with indocyanine green.

Authors:  D B HUNTON; J L BOLLMAN; H N HOFFMAN
Journal:  Gastroenterology       Date:  1960-12       Impact factor: 22.682

4.  Studies on the mechanism of the inhibition of galactose oxidation by ethanol.

Authors:  K J ISSELBACHER; S M KRANE
Journal:  J Biol Chem       Date:  1961-09       Impact factor: 5.157

5.  Galactose blood clearance as a measure of hepatic blood flow.

Authors:  N TYGSTRUP; K WINKLER
Journal:  Clin Sci       Date:  1958-02       Impact factor: 6.124

6.  Kinetics of galactose elimination.

Authors:  N TYGSTRUP; K WINKLER
Journal:  Acta Physiol Scand       Date:  1954-12-31

7.  A comparison of the bromsulphthalein and galactose elimination test in patients with either chronic bowel inflammation or alcoholic liver disease.

Authors:  L H Nilsson; E Hultman
Journal:  Scand J Gastroenterol       Date:  1974       Impact factor: 2.423

8.  Intravenous galactose elimination tests with and without ethanol loading in various clinical conditions.

Authors:  M P Salaspuro; Y A Kesäniemi
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

9.  An intravenous galactose tolerance test and its use in hepatobiliary diseases.

Authors:  B Tengström
Journal:  Acta Med Scand       Date:  1968 Jan-Feb

10.  Determination of the hepatic elimination capacity (Lm) of galactose by single injection.

Authors:  N Tygstrup
Journal:  Scand J Clin Lab Invest Suppl       Date:  1966
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.